INDEX VALUES   |

Home > Our Indexes > LSCIBC

Download Methodology

LifeSci Biotechnology Clinical Trials Index


The LifeSci Biotechnology Clinical Trials Index ("LSCIBC") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. The inception date for LSCIBC was November 3, 2014.

LSCIBCS&P 500
Prior Day Closing Value3831.244710.18
Prior Day Change %+1.38%+0.09%
Current Value
Current Day Change %+2.46%-0.01%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Apr 01, 2017)


No. of Constituents 69
Total Market Cap ($ in millions) 77,774
Mean Market Cap ($ in millions) 1,127
Median Market Cap ($ in millions) 815
Largest Constituent ($ in millions) 4,310
Smallest Constituent ($ in millions) 183

Market Cap Breakdown (Apr 01, 2017)


Top 10 Constituents (Apr 01, 2017)


Constituent Ticker Weight
Esperion Therapeutics Inc ESPR 3.35%
Tg Therapeutics Inc TGTX 2.75%
Global Blood Therapeutics In GBT 2.67%
Newlink Genetics Corp NLNK 2.62%
Portola Pharmaceuticals Inc PTLA 2.51%
Cara Therapeutics Inc CARA 2.48%
Achaogen Inc AKAO 2.06%
Clovis Oncology Inc CLVS 2.06%
Immunomedics Inc IMMU 2.02%
La Jolla Pharmaceutical Co LJPC 1.97%
Data Updated Monthly
Download All Constituents